Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up

@article{Simonin2016LymphocyteDI,
  title={Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up},
  author={Laurent Simonin and Elisabeth Pasquier and Christophe Leroyer and Divi Cornec and Julie Lemerle and Boutahar Bendaoud and Sophie Hillion and Jacques-Olivier Pers and Francis Couturaud and Yves Renaudineau},
  journal={Clinical Reviews in Allergy & Immunology},
  year={2016},
  volume={53},
  pages={14-27}
}
Among patients with venous thromboembolism (VTE), the persistent detection of antiphospholipid (aPL) antibodies (Ab) represents an independent high risk factor for recurrence. However, oral anticoagulation vitamin K antagonist therapy, frequently used in these patients, is problematic in assessing and/or confirming a diagnosis of primary aPL syndrome (pAPS), suggesting use of alternative strategies. For this reason, and by analogy with other autoimmune diseases, a flow cytometer approach… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 99 REFERENCES

European Study Group on Classification Criteria for Sjogren’s Syndrome (2002) Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed Clinic

C Vitali, S Bombardieri, +10 authors MH Weisman
  • Rev Allerg Immunol
  • 2017